Refine
Has Fulltext
- yes (167)
Is part of the Bibliography
- yes (167)
Year of publication
Document Type
- Journal article (90)
- Doctoral Thesis (77)
Keywords
- Strahlentherapie (22)
- Palliativmedizin (16)
- radiotherapy (16)
- Bestrahlung (9)
- Medizin (8)
- DNA damage (7)
- Radiotherapy (6)
- prostate cancer (6)
- rectal cancer (6)
- Strahlensensibilität (5)
- Tumor (5)
- breast cancer (5)
- radiosensitivity (5)
- Brustkrebs (4)
- IMRT (4)
- Lebensqualität (4)
- Prostatakrebs (4)
- Radioonkologie (4)
- Rektumkarzinom (4)
- quality assurance (4)
- toxicity (4)
- DNA repair (3)
- DNS-Reparatur (3)
- IGRT (3)
- NSCLC (3)
- NVP-BEZ235 (3)
- Osteopontin (3)
- PTEN (3)
- Radiosurgery (3)
- Tumorerkrankungen (3)
- VMAT (3)
- Versorgungsqualität (3)
- glioblastoma multiforme (3)
- head and neck cancer (3)
- hypofractionation (3)
- hypoxia (3)
- long-term outcome (3)
- lung cancer (3)
- stereotactic body radiation therapy (3)
- stereotactic irradiation (3)
- Brachytherapie (2)
- DNA double strand breaks (2)
- DNA-PK (2)
- DNS-Doppelstrangbruch (2)
- Glioblastom (2)
- Glioblastoma (2)
- Halcyon (2)
- Hirnmetastase (2)
- Hirnmetastasen (2)
- Hypoxie (2)
- IMAT (2)
- IPOS (2)
- Image-guidance (2)
- Intensitätsmodulierte Radiotherapie (2)
- Lebenssinn (2)
- Lungenmetastase (2)
- MRI (2)
- Meningioma (2)
- Nebenwirkungen (2)
- Nicht-kleinzelliges Bronchialkarzinom (2)
- Palliativbedarf (2)
- Palliative Care (2)
- Pflegeheim (2)
- Pflegeheimbewohner (2)
- Qualitätsindikatoren (2)
- Qualitätskontrolle (2)
- Radiochemotherapie (2)
- Radiosensitivity (2)
- Rezidiv (2)
- Screening (2)
- Stereotactic body radiotherapy (2)
- Strahlenbiologie (2)
- TGFβ1 (2)
- Therapieziel (2)
- Toxizität (2)
- Transkriptionsfaktor (2)
- Tumortherapie (2)
- Tumorzelle (2)
- Versorgungswünsche (2)
- adjuvant treatment (2)
- apoptosis (2)
- autophagy (2)
- cancer (2)
- cell cycle arrest (2)
- clinical trials (2)
- colony-forming assay (2)
- complementary alternative medicine (2)
- cone beam CT (2)
- depression (2)
- fatigue (2)
- histone H2AX (2)
- intensity modulated radiotherapy (2)
- irradiation (2)
- isocenter (2)
- megavoltage computed-tomography (2)
- migration (2)
- osteopontin (2)
- p53 (2)
- palliativ (2)
- palliative care (2)
- patterns of care (2)
- prostate-cancer (2)
- radiation sensitivity (2)
- radiochemotherapy (2)
- radiotherapy (RT) (2)
- salvage radiotherapy (2)
- simultaneous integrated boost (2)
- spine radiosurgery (2)
- stereotactic body radiotherapy (2)
- stereotaktische Bestrahlung (2)
- survival (2)
- vertebral metastases (2)
- Überleben (2)
- 2-step IMRT (1)
- 28 (1)
- 3D conformal silicone bolus (1)
- 3D printer (1)
- 3D-conformal radiotherapy (1)
- 3D-konformale Radiotherapie (1)
- 3D-konformaler Bolus (1)
- 4D-MRI (1)
- 68Ga-DOTATATE (1)
- A549 (1)
- ACR practice guidelines (1)
- ADT (1)
- ASCs (1)
- ATM (1)
- AUY-922 (1)
- AZD6244 (1)
- Adaptation (1)
- Adjuvante Behandlung (1)
- Adjuvante Therapie (1)
- Advance Care Planning (1)
- Adverse Events (1)
- Akt (1)
- Aktive Sterbehilfe (1)
- Androgendeprivationstherapie (1)
- Anorexia (1)
- Antigen CD44 (1)
- Appetitlosigkeit (1)
- Applikatorposition (1)
- Atherosclerotic plaque (1)
- Atovaquone (1)
- Automated analysis (1)
- Bedarf (1)
- Begrenzung (1)
- Begrenzung am Lebensende (1)
- Bestrahlung von Hirnmetastasen (1)
- Bestrahlungsplan (1)
- Bestrahlungstechniken (1)
- Betreuungsverfügung (1)
- Bewältigungsfähigkeiten (1)
- Brain cancer (1)
- Bronchialkarzinom (1)
- CA 9 (1)
- CD133 (1)
- CD44 (1)
- CD44v6 (1)
- CI-1040 (1)
- CIED malfunction; pacemaker (PM) (1)
- CNS cancer (1)
- CRISPR-Cas9 (1)
- Camptothecin (1)
- Cardiovascular risk factors (1)
- Cerebral small vessel disease (1)
- Chemotherapie (1)
- Chemotherapy (1)
- Chetomin (1)
- Clindamycin (1)
- Combination (1)
- Comet Assay (1)
- Comet assay (1)
- Comet-Assay (1)
- Cone-beam CT (1)
- Corticosteroids (1)
- Couch tracking (1)
- DMPO (1)
- DNA double-strand break (1)
- DNA double-strand breaks (1)
- DNA repair protraction (1)
- DNS-Schädigung (1)
- Delir (1)
- Depression (1)
- Depressivität (1)
- Distress Thermometer (1)
- Dixon (1)
- Dominant intraprostatic lesion (1)
- Dominante intraprostatische Läsion (1)
- Dosisanalyse (1)
- E-cadherin (1)
- EBRT (1)
- EORTC-BN20 (1)
- EORTC-QLQ-C15-PAL (1)
- ESAS (1)
- Earle-Kriterien (1)
- Earle-Kriterion (1)
- Effektivität (1)
- Einstellung zum Tod (1)
- Emotionsregulierung (1)
- Empowerment (1)
- End- of- Life- Care (1)
- End-of-Life Care (1)
- End-of-life-care (1)
- Endogene Hypoxiemarker (1)
- Enzyme Regulation (1)
- Ernährungstherapie (1)
- Extended field irradiation (1)
- FACS (1)
- FACS-Flow-Analysen (1)
- Fatigue (1)
- Fibroblast (1)
- Fibroblasten (1)
- Fibrozyt (1)
- Follicular Non-Hodgkin's Lymphoma (1)
- Follicular lymphoma (1)
- Follikuläres Non-Hodgkin-Lymphom (1)
- Frailty (1)
- Frame-based (1)
- Frame-less (1)
- Gastrointestinaltumor (1)
- Gebrechlichkeit (1)
- Gebärmutterhalskrebs (1)
- Genprodukt (1)
- Gesamttumorvolumen (1)
- Gimbaled tracking (1)
- Glioblastommodell (1)
- Glioma stem cells (1)
- Gliome (1)
- HECT Ligase (1)
- HIF 1 alpha (1)
- HIF-1 (1)
- HNO-Tumor (1)
- HNO-Tumore (1)
- HSP90 (1)
- HSP90 Inhibitor (1)
- HSP90 inhibitor (1)
- HSP90-Inhibition (1)
- HUWE1 (1)
- Head and neck cancer (1)
- Heterotope Ossifikation (1)
- High grade glioma (1)
- Histon gamma-H2AX (1)
- Histone gamma H2AX (1)
- Histone gamma-H2AX (1)
- Hitzeschock-Proteine (1)
- Hitzeschockprotein (1)
- Hitzeschockproteine (1)
- Hospiz (1)
- Humane Tumorzelllinien (1)
- Hypofraktionierung (1)
- Hüftgelenksprothese (1)
- IR (1)
- ImageJ plugin (1)
- Improved survival (1)
- Inanspruchnahme (1)
- Index lesion (1)
- Indexläsion (1)
- Inter-observer variability (1)
- Intraoperative Strahlentherapie (1)
- Ionizing radiation (1)
- JUN (1)
- Kernspintomographie (1)
- Klug Entscheiden (1)
- Koloniebildungstest (1)
- Kolonietest (1)
- Kopf-Hals-Tumore (1)
- Kosmetik (1)
- Krebs (1)
- Krebsforschung (1)
- Krebskranker (1)
- Krebspatient (1)
- Krebspatient:in (1)
- Körperrahmen (1)
- Körperstereotaktische Bestrahlung (1)
- Körperstereotaxie (1)
- Künstliche Ernährung (1)
- Langzeitradiochemotherapie (1)
- Lebensqualität und Lebenszeit (1)
- Lebenssende (1)
- Leitlinie (1)
- Locoregional recurrence (1)
- Luminespib (1)
- Lung cancer (1)
- Lung tumor (1)
- Lunge (1)
- Lungenfibrose (1)
- Lungentumor (1)
- Lymphogranulomatose (1)
- Lymphozyten (1)
- MEK-Inhibition (1)
- MLC tracking (1)
- MYC (1)
- Macrophage (1)
- Malnutrition (1)
- Mammakarzinom (1)
- Mangelernährung (1)
- Mastdarmkrebs (1)
- Maus-Lungen-Fibroblasten (1)
- Medicine (1)
- Meningeom (1)
- Mikrokern-Assay (1)
- Mikrokerntest (1)
- Molecular Biophysics (1)
- N-Myc down regulated gene 1 (1)
- NOTCH (1)
- NRS-2002 (1)
- NVP-AUY922 (1)
- Nachruf (1)
- Nampt (1)
- Nasenhaupthöhlentumore (1)
- Nasennebenhöhlentumore (1)
- Nebenwirkung (1)
- Nestin (1)
- Nichtmedikamentöse Therapien (1)
- Niedermolekulares Heparin (1)
- Non-rigid image registration (1)
- Normal tissue tolerance (1)
- Novel PI3K (1)
- OPN (1)
- Oncology (1)
- Open-source tool (1)
- Organ motion (1)
- Oropharynx-Karzinom (1)
- P14ARF (1)
- PBEF (1)
- PBRT (1)
- PD184352 (1)
- PHQ (1)
- PI3K (1)
- PI3K/mTOR-Inhibierung (1)
- PLNRT (1)
- PROM (1)
- PRRT (1)
- PSMA (1)
- PSMA PET/CT (1)
- Pain (1)
- Palliative Medicine (1)
- Palliative Sedierung (1)
- Palliativonkologie (1)
- Palliativpflege (1)
- Palliativtherapie (1)
- Palliativversorgung (1)
- Pancreascarcinom (1)
- Pankreaskarzinom (1)
- Patientenverfügung (1)
- Patterns of Care (1)
- Pelvic tumors (1)
- Peptide receptor radionuclide therapy (1)
- Perioperativer Verlauf (1)
- Peripheral blood lymphocytes (1)
- Pflegeheimbewohnende (1)
- Pflegeheimbewohnerin (1)
- Phase II trial (1)
- Phosphatidylinositolkinase <Phosphatidylinositol-3-Kinase> (1)
- Physiologische vs. medikamentöse Bewusstseinsminderung (1)
- Planungsstudie (1)
- Prevention (1)
- Primary radiation therapy (1)
- Primary ray therapy (1)
- Primäre Bestrahlung (1)
- Prognoseschätzung (1)
- Prognosescore (1)
- Prognosescores (1)
- Prognosetool (1)
- Prostata (1)
- Prostatakarzinom (1)
- Prostatakrebs Strahlentherapie (1)
- Prostataloge (1)
- Prostate carcinoma (1)
- Präoperative Bestrahlung (1)
- Pyrimethamin (1)
- Pyrimethamine (1)
- Quality of Life (1)
- Question Prompt (1)
- Rad50 (1)
- Radiation Oncology (1)
- Radiation biology (1)
- Radiation sensitivity (1)
- Radiochirurgie (1)
- Radiosensibilisatoren (1)
- Radiosensibilisierung (1)
- Radiotherapy treatment planning (1)
- Re-irradiation (1)
- Rectal cancer (1)
- Replication (1)
- Replikation (1)
- Resilienz (1)
- Respiration correlated imaging (1)
- Respiratory induced tumor motion (1)
- Response shift (1)
- Rezidivbestrahlung (1)
- Rezidivrate (1)
- Risikoorgandosen (1)
- Robotic tracking (1)
- S3-Leitlinie Palliativmedizin (1)
- SBRT (1)
- SHRSP (1)
- SNB19 (1)
- SPICT (1)
- Salvage-Radiotherapie (1)
- Sauerstoffeffekt (1)
- Schmerz (1)
- Schmerzerfassung (1)
- Schädel (1)
- Shared Decision Making (1)
- Short dsRNA oligonucleotides (1)
- Somatostatin receptor (1)
- Spinal metastases (1)
- Spinal metastasis (1)
- Spiramycin (1)
- Stadiendifferenzierung (1)
- Stage Conversion (1)
- Step and Shoot IMRT (1)
- Sterbephase (1)
- Stereotactic (1)
- Stereotactic radiation (1)
- Stereotaxie (1)
- Strahlenempfindlichkeit (1)
- Strahlenpneumonitis (1)
- Strahlenresistenz (1)
- Strahlensensibilisator (1)
- Strahlentherapie bei Morbus Hodgkin (1)
- Structural Biology (1)
- Sulfadiazin (1)
- Sulfadiazine (1)
- Survivin (1)
- Symptome (1)
- Symptomlinderung (1)
- Symptommanagement (1)
- Synergy (1)
- TGF-beta antibody (1)
- TME (1)
- Tablet (1)
- Tablet PC (1)
- Temozolomide (1)
- Thromboembolieprophylaxe (1)
- Thrombose (1)
- Total nodal irradiation (1)
- Toxizitäten (1)
- Toxoplasma gondii (1)
- Transforming Growth Factor beta (1)
- Translational and rotational motion (1)
- Tumooxygenierung (1)
- Tumorpatienten (1)
- Tumorzellen (1)
- Ubiquitin (1)
- Ultra-Short Screening (1)
- Universitätsklinik Würzburg (1)
- Universitätsklinikum Würzburg (1)
- Unterstützungsbedarf in der Radioonkologie (1)
- Unterstützungsmöglichkeiten (1)
- Uroonkologie (1)
- VEGF (1)
- VIBE (1)
- VSOP (1)
- Validierung (1)
- Verhalten und Verhaltensmechanismen (1)
- Verlagerung (1)
- Verlegung <Ortswechsel> (1)
- Versorgungsplanung (1)
- Volumetric modulated arc therapy (1)
- Vorsorgevollmacht (1)
- Werner Bohndorf (1)
- Winston‐Lutz test (1)
- Wirbelsäulenbestrahlung (1)
- Working Committee on Quality Indicators (1)
- X-Ray Chrystallography (1)
- Yoga (1)
- Zellforschung (1)
- Zervixkarzinom (1)
- \(\gamma\)h2ax (1)
- accelerated hyperfractionation (1)
- acute toxicity (1)
- adaptation (1)
- adaption (1)
- adaptive radiotherapy (1)
- adenocarcinoma (1)
- adipocytokines (1)
- adipose tissue-derived stromal cells (1)
- adjuvant (1)
- adjuvante Radiotherapie (1)
- adrenal tumours (1)
- adrenocortical carcinoma (ACC) (1)
- advanced technology (1)
- altered fractionation (1)
- anxiety (1)
- attitude to death (1)
- auto-planning (1)
- automatisiertes Screening (1)
- battery depletion (1)
- behavior and behaviormechanisms (1)
- beta-catenin (1)
- biochemical relapse free survival (1)
- blood lymphocytes (1)
- body-frame (1)
- boost (1)
- brachytherapy (1)
- brain cancer (1)
- brain tumor (1)
- brain tumours (1)
- breastcancer (1)
- breath-hold (1)
- bronchial carcinoma (1)
- buildup region (1)
- cancer patients (1)
- capacitance (1)
- cardiac implantable electronic devices (CIED) (1)
- cardiac resynchronization therapy (CRT) (1)
- cell labeling (1)
- cell membranes (1)
- cell proliferation (1)
- cell velocimetry (1)
- cervical cancer (1)
- chemoradiotherapy (1)
- chemotherapy (1)
- choosing wisely (1)
- clinical application (1)
- colony survival (1)
- colorectal cancer (1)
- comet assay (1)
- cone-beam ct (1)
- conformal radiotherapy (1)
- coping skills (1)
- cosmetic (1)
- credentialing (1)
- cyberknife radiosurgery (1)
- cytoskeleton (1)
- data acquisition (1)
- deformable image registration (1)
- delineation (1)
- density (1)
- depth dose curves (1)
- diode (1)
- dominant intraprostatic lesion (1)
- dose accumulation (1)
- dose escalation (1)
- dose evaluation (1)
- dose to OARs (1)
- doses of the organs of risk (1)
- dosimetry (1)
- double arc (1)
- dual-energy CT (1)
- dual-source CT (1)
- dying phase (1)
- echinocytes (1)
- echo planar imaging (1)
- effective point of measurement (1)
- electrometer (1)
- electroporation (1)
- emotional regulation (1)
- end-of-life (1)
- expression (1)
- external beam radiotherapy (EBRT) (1)
- fibroblasts (1)
- fibrocyt (1)
- flat silicone bolus (1)
- focal radiotherapy (1)
- foci (1)
- fortgeschrittene Tumorerkrankung (1)
- full arc (1)
- functional magnetic resonance imaging (1)
- fused deposition modeling (1)
- fused deposition modeling (FDM) (1)
- gadoxetic acid (1)
- gamma H2AX-foci (1)
- gastric cancer (1)
- gastrointestinal tumor (1)
- glioblastoma (1)
- glioblastoma cell lines (1)
- guidance (1)
- hausärztlich (1)
- head (1)
- head and neck squamous cell carcinoma (1)
- heat shock protein (1)
- heat shock proteins (1)
- helical tomotherapy (1)
- hemoglobin jet (1)
- heterotopic ossification (1)
- high-dose-rate (HDR) brachytherapy (1)
- high-dose-rate brachytherapy boost (1)
- hip replacement (1)
- histone γH2AX (1)
- hospital-based palliative care (1)
- human cancer diseases (1)
- hypofraktionierte (1)
- hypotonic (1)
- illness-death model (1)
- image-guided radiation therapy (1)
- imaging techniques (1)
- implantable cardioverter defibrillator (ICD) (1)
- in vivo (1)
- in-vitro Modell (1)
- in-vitro model (1)
- individual case review (1)
- individual radiosensitivity (1)
- individual silicone bolus (1)
- individueller Bolus (1)
- inhibitor (1)
- intensity-modulated radiation therapy (1)
- intensity-modulated radiotherapy (1)
- intraoperative Boostbestrahlung (1)
- ionization chambers (1)
- iron oxide nanoparticles (1)
- irradiated fibroblasts (1)
- irradiation of the spine (1)
- irridation (1)
- isotonic (1)
- konservative Tumortherapie (1)
- leaf width (1)
- life-quality (1)
- limitations (1)
- liver metastases (1)
- liver oligometastases (1)
- lokale Dosisaufsättigung (1)
- lokale Tumorkontrolle (1)
- long-course radiochemotherapy (1)
- long-term effects (1)
- lung (1)
- lung fibroblasts (1)
- lung metastases (1)
- lung metastasis (1)
- lymphocytes (1)
- mTOR (1)
- mTOR Inhibitor (1)
- macroscopic recurrence (1)
- matched filters (1)
- membrane characteristics (1)
- membrane proteins (1)
- meningioma (1)
- metastasis-directed therapy (1)
- methods (1)
- micro-chambers (1)
- micro-ionization chambers (1)
- microionization chambers (1)
- micronucleus assay (1)
- micronucleus-assay (1)
- microvilli (1)
- mind-body intervention (1)
- mind–body intervention (1)
- modulated arc therapy (1)
- mouse model (1)
- multi-leaf collimator (1)
- multiple brain metastases (1)
- neck cancer (1)
- neoadjuvant (1)
- nicht kleinzelliges Bronchialkarzinom (1)
- nicht-maligne Zellen (1)
- nichtkleinzelliges Bronchialdarzinom (1)
- nicotinamide phosphoribosyltransferase (1)
- non-muscle myosin (1)
- non-small cell lung cancer (1)
- non-small-cell lung cancer (1)
- nonkoplanar (1)
- obesity (1)
- oligo-recurrence (1)
- oligometastases (1)
- oligorecurrence (1)
- online adaption (1)
- optimization (1)
- oral mucositis (1)
- oropharyngeal cancer (1)
- outcome (1)
- outcomes research (1)
- overexpression (1)
- oversupply (1)
- oxidative DNA damage (1)
- oxygen effect (1)
- palliative (1)
- palliative Sedierung (1)
- palliative medicine (1)
- palliative-medicine (1)
- paraspinal tumors (1)
- partial arc (1)
- partitioning analysis RPA (1)
- patient-reported outcome (1)
- pediatric (1)
- pelvic lymph node radiotherapy (1)
- pelvine Lymphabflüsse (1)
- penumbra (1)
- peptide receptor radionuclide therapy (PRRT) (1)
- percent depth dose curves (1)
- perioperative changes (1)
- peripheral blood lymphocytes (1)
- phlorizin (1)
- phosphorylation (1)
- plan comparison (1)
- planning study (1)
- planning variability (1)
- plans (1)
- polarity (1)
- position of applicator (1)
- praeoperative irradiation (1)
- prevention (1)
- prognostic index (1)
- prognostic tools (1)
- prognostic value (1)
- propensity score matching (1)
- prostate Imaging Reporting and Data System (1)
- prostate bed radiotherapy (1)
- prostate gland carcinoma (1)
- prädiktiver Test (1)
- psychischer Stress (1)
- psychological distress (1)
- quaility indicator (1)
- quality indicators (1)
- quality of live (1)
- questionnaire (1)
- radiation biology (1)
- radiation dose (1)
- radiation oncology (1)
- radiation pneumonitis (1)
- radiation therapy (1)
- radiation-therapy (1)
- radiogene Lungenfibrose (1)
- radiogenic lung fibrosis (1)
- radiosensibility (1)
- radiosensitization (1)
- radiosensitizers (1)
- radiosurgery (1)
- re-irradiation (1)
- re-planning (1)
- recurrence (1)
- relative dosimetry (1)
- reminder e-mails (1)
- repair (1)
- risk (1)
- risk score (1)
- robotic table motion (1)
- saftey margin (1)
- salvage (1)
- scanning electron microscopy (1)
- scatter radiation (1)
- set-up error (1)
- setup verification (1)
- signal filtering (1)
- signaling pathways (1)
- simultan integrierter Boost (1)
- single arc (1)
- spectral CT (1)
- spine Radiosurgery (1)
- spine tumors (1)
- squamous cell carcinoma (1)
- standard (1)
- statistical data (1)
- stereotactic radiotherapy (1)
- strategies (1)
- supportive care (1)
- surface dose measurement (1)
- survival rate (1)
- symptom control (1)
- symptoms (1)
- sync-oligometastases (1)
- temozolomide (1)
- therapy (1)
- thromboembolism prophylaxis (1)
- tracking (1)
- transcription factor (1)
- transperineal ultrasound (1)
- transportome (1)
- treated metastases control (1)
- treatment (1)
- treatment plan (1)
- tumor biomarker (1)
- tumor cell lines (1)
- tumor control probability (1)
- validation (1)
- variability (1)
- virtual isocenter (1)
- virtual isocentre (1)
- virtual non-contrast (1)
- visfatin (1)
- visfatin levels (1)
- volume regulation (1)
- volumetric modulated arc therapy (1)
- volumetric modulated arc therapy (VMAT) (1)
- whole breast irradiation (1)
- whole-brain radiotherapy (1)
- wound healing (1)
- yoga (1)
- zinc oxide nanoparticles (1)
- Überlebensrate (1)
- Überlebenszeitanalyse (1)
- Überversorgung (1)
- ∆Np63 (1)
Institute
- Klinik und Poliklinik für Strahlentherapie (167) (remove)
Sonstige beteiligte Institutionen
In locally advanced rectal cancer (LARC) neoadjuvant chemoradiotherapy is regarded as standard treatment. We assessed acute toxicities in patients receiving conventional 3D-conformal radiotherapy (3D-RT) and correlated them with dosimetric parameters after re-planning with volumetric modulated arc therapy (VMAT). Patients were randomized within the multicenter CAO/ARO/AIO-12 trial and received 50.4 Gy in 28 fractions and simultaneous chemotherapy with fluorouracil and oxaliplatin. Organs at risk (OAR) were contoured in a standardized approach. Acute toxicities and dose volume histogram parameters of 3D-RT plans were compared to retrospectively calculated VMAT plans. From 08/2015 to 01/2018, 35 patients with LARC were treated at one study center. Thirty-four patients were analyzed of whom 1 (3%) was UICC stage II and 33 (97%) patients were UICC stage III. Grade 3 acute toxicities occurred in 5 patients (15%). Patients with acute grade 1 cystitis (n = 9) had significantly higher D\(_{mean}\) values for bladder (29.4 Gy vs. 25.2 Gy, p < 0.01) compared to patients without bladder toxicities. Acute diarrhea was associated with small bowel volume (grade 2: 870.1 ccm vs. grade 0–1: 647.3 ccm; p < 0.01) and with the irradiated volumes V5 to V50. Using VMAT planning, we could reduce mean doses and irradiated volumes for all OAR: D\(_{mean}\) bladder (21.9 Gy vs. 26.3 Gy, p < 0.01), small bowel volumes V5–V45 (p < 0.01), D\(_{mean}\) anal sphincter (34.6 Gy vs. 35.6 Gy, p < 0.01) and D\(_{mean}\) femoral heads (right 11.4 Gy vs. 25.9 Gy, left 12.5 Gy vs. 26.6 Gy, p < 0.01). Acute small bowel and bladder toxicities were dose and volume dependent. Dose and volume sparing for all OAR could be achieved through VMAT planning and might result in less acute toxicities.
Purpose
Examine the effects of an 8-week yoga therapy on fatigue in patients with different types of cancer.
Methods
A total of 173 cancer patients suffering from mild to severe fatigue were randomly allocated to yoga intervention (n = 84) (IG) versus waitlist control group (CG) (n = 88). Yoga therapy consisted of eight weekly sessions with 60 min each. The primary outcome was self-reported fatigue symptoms. Secondary outcomes were symptoms of depression and quality of life (QoL). Data were assessed using questionnaires before (T0) and after yoga therapy for IG versus waiting period for CG (T1).
Results
A stronger reduction of general fatigue (P = .033), physical fatigue (P = .048), and depression (P < .001) as well as a stronger increase in QoL (P = .002) was found for patients who attended 7 or 8 sessions compared with controls. Within the yoga group, both higher attendance rate and lower T0-fatigue were significant predictors of lower T1-fatigue (P ≤ .001). Exploratory results revealed that women with breast cancer report a higher reduction of fatigue than women with other types of cancer (P = .016) after yoga therapy.
Conclusion
The findings support the assumption that yoga therapy is useful to reduce cancer-related fatigue, especially for the physical aspects of fatigue. Women with breast cancer seem to benefit most, and higher attendance rate results in greater reduction of fatigue.
Trial registration
German Clinical Trials Register DRKS00016034
Objective
To examine the efficacy of reminder e-mails to continue yoga therapy on practice frequency and fatigue in cancer patients and long-term effects of yoga on fatigue, depression, and quality of life.
Methology
One hundred two cancer patients who completed an 8-week yoga therapy were randomly allocated to two groups: reminder (N = 51) vs. no-reminder group (N = 51). After completing yoga therapy, the reminder group received weekly e-mails for 24 weeks, which reminded them of practicing yoga, whereas the no-reminder group did not. Primary outcomes were fatigue and practice frequency, and long-term outcomes were fatigue, depression, and quality of life. Data were assessed using questionnaires after yoga therapy (T1) and 6 months after completing yoga therapy (T2).
Result
A significantly stronger reduction of general (p = 0.038, d = 0.42) and emotional fatigue (p = 0.004, d = 0.59) and a higher increase of practice frequency (p = 0.015, d = 0.52) between T1 and T2 were found for the reminder group compared to the no-reminder group. In the mediation model, practice frequency as a mediator partially explained the changes in emotional fatigue (indirect effect B = - 0.10). Long-term effects of yoga therapy regarding fatigue, depression, and quality of life were found (F > 7.46, p < 0.001, d > 0.54).
Conclusion
Weekly reminder e-mails after yoga therapy can positively affect general and emotional fatigue and help cancer patients with fatigue establish a regular yoga practice at home. However, higher practice frequency did not lead to higher physical or cognitive fatigue improvement, suggesting other factors that mediate efficacy on physical or cognitive fatigue, such as mindfulness or side effects of therapy.
Die primäre Bestrahlung stellt eine kurative Therapieoption des lokalen Prostatakarzinoms dar. In den meisten Fällen weist das Prostatakarzinom Multifokalität auf. Studien zeigen, dass die dominante intraprostatische Läsion (DIL), oder Indexläsion, bedeutend für das Progressionsrisiko ist. Der Einbezug einer MRT-Bildgebung in das Management des Prostatakarzinoms ermöglicht hierbei eine überlegene Gewebebeurteilung. In dieser retrospektiven Arbeit wurden 54 Patientenfälle inkludiert, die im Zeitraum 03/2015 bis 03/2017 eine primäre, kurative Bestrahlung eines Prostatakarzinoms am Uniklinikum Würzburg erhalten haben. Es wurde evaluiert, ob im prätherapeutischen Bestrahlungsplanungs-MRT die Identifikation und Konturierung einer DIL möglich ist. In einem weiteren Schritt wurde die Dosisabdeckung der DIL im Bestrahlungsplan analysiert. Zudem wurden die MRT-Befunde mit den histopathologischen Stanzbiopsiebefunden bezüglich der Tumordetektion verglichen und auf Übereinstimmung geprüft.
Functional magnetic resonance imaging (fMRI) has become a powerful and influential method to non-invasively study neuronal brain activity. For this purpose, the blood oxygenation level-dependent (BOLD) effect is most widely used. T2* weighted echo planar imaging (EPI) is BOLD sensitive and the prevailing fMRI acquisition technique. Here, we present an alternative to its standard Cartesian recordings, i.e. k-space density weighted EPI, which is expected to increase the signal-to-noise ratio in fMRI data. Based on in vitro and in vivo pilot measurements, we show that fMRI by k-space density weighted EPI is feasible and that this new acquisition technique in fact boosted spatial and temporal SNR as well as the detection of local fMRI activations. Spatial resolution, spatial response function and echo time were identical for density weighted and conventional Cartesian EPI. The signal-to-noise ratio gain of density weighting can improve activation detection and has the potential to further increase the sensitivity of fMRI investigations.
Es erfolgte eine Evaluierung von Bestrahlungsdaten aus der Strahlentherapie der Universitätsklinik Würzburg von 435 Patienten mit biochemischen oder klinischen Rezidiv des Prostatakarzinoms. Der primäre Endpunkt war das biochemisch rezidivfreie Überleben. Sekundäre Endpunkte waren das Auftreten von Fernmetastasen und das Versterben der Patienten. Zudem wurde der Einfluss patienten-, tumor-, und behandlungsspezifischer Faktoren überprüft.
Background
Tumor hypoxia is a known risk factor for reduced response to radiotherapy. The evaluation of noninvasive methods for the detection of hypoxia is therefore of interest. Osteopontin (OPN) has been discussed as an endogenous hypoxia biomarker. It is overexpressed in many cancers and is involved in tumor progression and metastasis.
Methods
To examine the influence of hypoxia and irradiation on osteopontin expression we used different cell lines (head and neck cancer (Cal27 and FaDu) and glioblastoma multiforme (U251 and U87)). Cells were treated with hypoxia for 24 h and were then irradiated with doses of 2 and 8 Gy. Osteopontin expression was analyzed on mRNA level by quantitative real-time RT-PCR (qPCR) and on protein level by western blot. Cell culture supernatants were evaluated for secreted OPN by ELISA.
Results
Hypoxia caused an increase in osteopontin protein expression in all cell lines. In Cal27 a corresponding increase in OPN mRNA expression was observed. In contrast the other cell lines showed a reduced mRNA expression under hypoxic conditions. After irradiation OPN mRNA expression raised slightly in FaDu and U87 cells while it was reduced in U251 and stable in Cal27 cells under normoxia. The combined treatment (hypoxia and irradiation) led to a slight increase of OPN mRNA after 2 Gy in U251 (24 h) and in U87 (24 and 48 h) cell lines falling back to base line after 8 Gy. This effect was not seen in Cal27 or in FaDu cells. Secreted OPN was detected only in the two glioblastoma cell lines with reduced protein levels under hypoxic conditions. Again the combined treatment resulted in a minor increase in OPN secretion 48 hours after irradiation with 8 Gy.
Conclusion
Osteopontin expression is strongly modulated by hypoxia and only to a minor extent by irradiation. Intracellular OPN homeostasis seems to vary considerably between cell lines. This may explain the partly conflicting results concerning response prediction and prognosis in the clinical setting.
Background: To introduce a novel method of patient positioning for high precision intracranial radiotherapy. Methods: An infrared(IR)-array, reproducibly attached to the patient via a vacuum-mouthpiece(vMP) and connected to the table via a 6 degree-of-freedom(DoF) mechanical arm serves as positioning and fixation system. After IR-based manual prepositioning to rough treatment position and fixation of the mechanical arm, a cone-beam CT(CBCT) is performed. A robotic 6 DoF treatment couch (HexaPOD™) then automatically corrects all remaining translations and rotations. This absolute position of infrared markers at the first fraction acts as reference for the following fractions where patients are manually prepositioned to within ± 2 mm and ± 2° of this IR reference position prior to final HexaPOD-based correction; consequently CBCT imaging is only required once at the first treatment fraction. The preclinical feasibility and attainable repositioning accuracy of this method was evaluated on a phantom and human volunteers as was the clinical efficacy on 7 pilot study patients. Results: Phantom and volunteer manual IR-based prepositioning to within ± 2 mm and ± 2° in 6DoF was possible within a mean(± SD) of 90 ± 31 and 56 ± 22 seconds respectively. Mean phantom translational and rotational precision after 6 DoF corrections by the HexaPOD was 0.2 ± 0.2 mm and 0.7 ± 0.8° respectively. For the actual patient collective, the mean 3D vector for inter-treatment repositioning accuracy (n = 102) was 1.6 ± 0.8 mm while intra-fraction movement (n = 110) was 0.6 ± 0.4 mm. Conclusions: This novel semi-automatic 6DoF IR-based system has been shown to compare favourably with existing non-invasive intracranial repeat fixation systems with respect to handling, reproducibility and, more importantly, intrafraction rigidity. Some advantages are full cranial positioning flexibility for single and fractionated IGRT treatments and possibly increased patient comfort.
Background
The management of rectal cancer (RC) has substantially changed over the last decades with the implementation of neoadjuvant chemoradiotherapy, adjuvant therapy and improved surgery such as total mesorectal excision (TME). It remains unclear in which way these approaches overall influenced the rate of local recurrence and overall survival.
Methods
Clinical, histological and survival data of 658 out of 662 consecutive patients with RC were analyzed for treatment and prognostic factors from a prospectively expanded single-institutional database. Findings were then stratified according to time of diagnosis in patient groups treated between 1993 and 2001 and 2002 and 2010.
Results
The study population included 658 consecutive patients with rectal cancer between 1993 and 2010. Follow up data was available for 99.6% of all 662 treated patients. During the time period between 2002 and 2010 significantly more patients underwent neoadjuvant chemoradiotherapy (17.6% vs. 60%) and adjuvant chemotherapy (37.9% vs. 58.4%). Also, the rate of reported TME during surgery increased. The rate of local or distant metastasis decreased over time, and tumor related 5-year survival increased significantly with from 60% to 79%.
Conclusion
In our study population, the implementation of treatment changes over the last decade improved the patient’s outcome significantly. Improvements were most evident for UICC stage III rectal cancer.
Experimentelle FACS-Flow-Analysen im Kontext einer radiogenen Lungenfibrose zur Veränderung der Zellproliferation von Maus-Lungen-Fibroblasten unter dem Einfluss von Kulturüberständen bestrahlter Fibroblasten. Additiv einzelne Versuche mit Antikörperzugabe gegen TGF-beta zur Evaluation eines hemmenden Effektes auf eine postulierte Arretierung der Fibroblasten in der G1-Phase der Zellteilung durch die Zytokine der Kulturüberstände bestrahlter Maus-Lungen-Fibroblasten.